Evidence map›Paper›PMID 35095909›Full record

ReviewFrontiers in immunology2021

Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses.

Jinwu Peng, Qiuju Liang, Zhijie Xu, Yuan Cai, Bi Peng, Jianbo Li, Wenqin Zhang, Fanhua Kang, Qianhui Hong, Yuanliang Yan and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jinwu PengDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Qiuju LiangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Zhijie XuDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Yuan CaiDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Bi PengDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Jianbo LiDepartment of Pathology, Xiangya Changde Hospital, Changde, China.
Wenqin ZhangDepartment of Pathology, Xiangya Changde Hospital, Changde, China.
Fanhua KangDepartment of Pathology, Xiangya Changde Hospital, Changde, China.
Qianhui HongDepartment of Pathology, Xiangya Changde Hospital, Changde, China.
Yuanliang YanDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Mingyu ZhangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xiangya Hospital Central South University · CNThe First People's Hospital of Changde · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes, the small extracellular vesicles, are released by multiple cell types, including tumor cells, and represent a novel avenue for intercellular communication

Indexed as

ImmunomodulationAnimalsBiomarkers, TumorCell CommunicationCell ProliferationDatabases, GeneticDisease ManagementDisease SusceptibilityExosomesGliomaHumansMicroRNAsMolecular Targeted TherapyNeovascularization, PathologicRNA TransportSignal TransductionBiomarkers, TumorMicroRNAsbiomarkerexosomesgliomamicroRNAstherapeutic response

Identifiers

PMID35095909
PMCPMC8796999
OpenAlexW4206693266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.